Follow
Jean Martin Beaulieu
Jean Martin Beaulieu
Department of Pharmacology and Toxicology, University of Toronto
Verified email at utoronto.ca
Title
Cited by
Cited by
Year
The physiology, signaling, and pharmacology of dopamine receptors
JM Beaulieu, RR Gainetdinov
Pharmacological reviews 63 (1), 182-217, 2011
32152011
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu, TD Sotnikova, S Marion, RJ Lefkowitz, RR Gainetdinov, ...
Cell 122 (2), 261-273, 2005
11682005
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu, TD Sotnikova, WD Yao, L Kockeritz, JR Woodgett, ...
Proceedings of the National Academy of Sciences 101 (14), 5099-5104, 2004
9302004
Tryptophan hydroxylase-2 controls brain serotonin synthesis
X Zhang, JM Beaulieu, TD Sotnikova, RR Gainetdinov, MG Caron
Science 305 (5681), 217-217, 2004
8492004
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
7482019
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression
X Zhang, RR Gainetdinov, JM Beaulieu, TD Sotnikova, LH Burch, ...
Neuron 45 (1), 11-16, 2005
6322005
Dopamine receptors–IUPHAR R eview 13
JM Beaulieu, S Espinoza, RR Gainetdinov
British journal of pharmacology 172 (1), 1-23, 2015
6252015
Akt/GSK3 signaling in the action of psychotropic drugs
JM Beaulieu, RR Gainetdinov, MG Caron
Annual review of pharmacology and toxicology 49, 327-347, 2009
6112009
The Akt–GSK-3 signaling cascade in the actions of dopamine
JM Beaulieu, RR Gainetdinov, MG Caron
Trends in pharmacological sciences 28 (4), 166-172, 2007
4912007
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl homeostasis
F Ferrini, T Trang, TAM Mattioli, S Laffray, T Del'Guidice, LE Lorenzo, ...
Nature neuroscience 16 (2), 183-192, 2013
4622013
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
JM Beaulieu, X Zhang, RM Rodriguiz, TD Sotnikova, MJ Cools, ...
Proceedings of the National Academy of Sciences 105 (4), 1333-1338, 2008
4532008
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 178, S27-S156, 2021
4502021
A β-arrestin 2 signaling complex mediates lithium action on behavior
JM Beaulieu, S Marion, RM Rodriguiz, IO Medvedev, TD Sotnikova, ...
Cell 132 (1), 125-136, 2008
4442008
Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity
WD Yao, RR Gainetdinov, MI Arbuckle, TD Sotnikova, M Cyr, JM Beaulieu, ...
Neuron 41 (4), 625-638, 2004
4152004
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
B Masri, A Salahpour, M Didriksen, V Ghisi, JM Beaulieu, RR Gainetdinov, ...
Proceedings of the National Academy of Sciences 105 (36), 13656-13661, 2008
3682008
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
JM Beaulieu, E Tirotta, TD Sotnikova, B Masri, A Salahpour, ...
Journal of Neuroscience 27 (4), 881-885, 2007
3142007
Inhibition of GSK3 by lithium, from single molecules to signaling networks
L Freland, JM Beaulieu
Frontiers in molecular neuroscience 5, 14, 2012
3052012
Late onset death of motor neurons in mice overexpressing wild-type peripherin
JM Beaulieu, MD Nguyen, JP Julien
The Journal of cell biology 147 (3), 531-544, 1999
2901999
Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury
M Lalancette-Hébert, V Swarup, JM Beaulieu, I Bohacek, E Abdelhamid, ...
Journal of Neuroscience 32 (30), 10383-10395, 2012
2812012
A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
JM Beaulieu
Journal of Psychiatry and Neuroscience 37 (1), 7-16, 2012
2772012
The system can't perform the operation now. Try again later.
Articles 1–20